Adopting the MRD Strategy to Optimize Post-operation Adjuvant Therapies for Early Stage Breast Cancer

Recruiting

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(3 sites)

China

Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing Municipality

Beijing Huanxing Cancer Hospital, Beijing, Beijing Municipality

Cancer Hospital, Chinese Academy of Medical Sciences, Hebei Center, Langfang, Hebei